No Data
No Data
Amneal Announces FDA Approval For Dementia And Oncology Therapies, Tentative Approval For IBS-D Drug; 180-Day Exclusivity For Memantine/Donepezil
Express News | Amneal Pharma - Approval of Three Important Therapies for Dementia, Oncology and Gastrointestinal Disease
Express News | Amneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin
RBC on FDA's Third Tentative Approval For Rifaximin 550mg to Amneal Pharmaceuticals
FDA Grants Tentative Approval for Amneal Generic of Bausch Health's Xiafan
Is Amneal Pharmaceuticals (AMRX) Stock Outpacing Its Medical Peers This Year?